SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-24-000293
Filing Date
2024-01-05
Accepted
2024-01-05 21:00:57
Documents
1
Period of Report
2024-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3717
  Complete submission text file 0001654954-24-000293.txt   5295
Mailing Address 1042-B NORTH EL CAMINO REAL, SUITE 430 ENCINITAS CA 92024
Business Address
HALE DAVID F (Reporting) CIK: 0001024004 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40739 | Film No.: 24518096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Issuer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)